US 10632184
Compositions and methods for stabilizing alphaviruses with improved formulations
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 10632184 (Compositions and methods for stabilizing alphaviruses with improved formulations) held by Takeda Vaccines, Inc. expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 62
- CPC classes
- A61K, A61K2039/5254, A61K39/12, A61K47/183, A61K47/26